Up-front Payments in Platform Technology Deals, Revisited
Executive SummaryWhich biotechnology platforms attract the highest up-front payments in alliances?
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.